• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations

Opinion
Video

Experts discuss the benefits of implementing and operationalizing bispecifics in the community oncology setting.

Related Videos
1 expert is featured in this series.
Nihar Desai, MD, MPH
Dr Toon Van Gorp
Andrew Kuykendall, MD, Moffitt Cancer Center
Barry Byrne, MD
Giulio Cossu, MD
Dr Toon Van Gorp
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.